Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Solovic

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Antibiotics (Basel, Switzerland)|November 27, 2021
Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis NetworkLia D'Ambrosio, Rosella Centis, Claudia C Dobler, et al.
The European Respiratory Journal|March 12, 2016
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, et al.
The European Respiratory Journal|April 15, 2016
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant TuberculosisSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Tuberculosis incidence in foreign-born people residing in European countries in 2020Anca Vasiliu, Niklas Köhler, Ekkehardt Altpeter, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Antibiotics (Basel, Switzerland)|November 27, 2021
Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis NetworkLia D'Ambrosio, Rosella Centis, Claudia C Dobler, et al.
The European Respiratory Journal|March 12, 2016
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, et al.
The European Respiratory Journal|April 15, 2016
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant TuberculosisSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Tuberculosis incidence in foreign-born people residing in European countries in 2020Anca Vasiliu, Niklas Köhler, Ekkehardt Altpeter, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Pageof 3